HIV molecular immunology database

 

Search Antibody Database

Found 1 matching record:

Displaying record number 575

Download this epitope record as JSON.

MAb ID 9201
HXB2 Location gp160(471-482)
DNA(7635..7670)
gp160 Epitope Map
Author Location gp120(475-486 LAI)
Research Contact Du Pont de Nemours, Boston, MA
Epitope GGGDMRDNWRSE Epitope Alignment
GGGDMRDNWRSE epitope logo
Subtype B
Ab Type gp120 C5
Neutralizing  
Species (Isotype) mouse(IgG1)
Patient  
Immunogen vaccine
Keywords antibody binding site

Vaccine Details

Vaccine type peptide

Notes

Showing 2 of 2 notes.

References

Showing 2 of 2 references.

McDougal1996 J. S. McDougal, M. S. Kennedy, S. L. Orloff, J. K. A. Nicholson, and T. J. Spira. Mechanisms of Human Immunodeficiency Virus Type 1 (HIV-1) Neutralization: Irreversible Inactivation of Infectivity by Anti-HIV-1 Antibody. J. Virol., 70:5236-5245, 1996. Studies of polyclonal sera autologous virus inactivation indicates that in individuals over time, viral populations emerge that are resistant to inactivating effects of earlier sera. PubMed ID: 8764033. Show all entries for this paper.

Dairou2004 Julien Dairou, Christine Vever-Bizet, and Daniel Brault. Interaction of Sulfonated Anionic Porphyrins with HIV Glycoprotein gp120: Photodamages Revealed by Inhibition of Antibody Binding to V3 and C5 Domains. Antiviral. Res., 61(1):37-47, Jan 2004. PubMed ID: 14670592. Show all entries for this paper.


Questions or comments? Contact us at immuno@lanl.gov
 
Managed by Triad National Security, LLC for the U.S. Department of Energy’s National Nuclear Security Administration
Copyright © 2022 Triad National Security, LLC | Disclaimer/Privacy

Dept of Health & Human Services Los Alamos National Institutes of Health